CN1242429A - Papain blood group diagnose reagent prepn. method - Google Patents
Papain blood group diagnose reagent prepn. method Download PDFInfo
- Publication number
- CN1242429A CN1242429A CN 99108817 CN99108817A CN1242429A CN 1242429 A CN1242429 A CN 1242429A CN 99108817 CN99108817 CN 99108817 CN 99108817 A CN99108817 A CN 99108817A CN 1242429 A CN1242429 A CN 1242429A
- Authority
- CN
- China
- Prior art keywords
- blood group
- papoid
- latex
- pawpaw
- utilizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 50
- 239000008280 blood Substances 0.000 title claims abstract description 50
- 238000000034 method Methods 0.000 title claims abstract description 31
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 18
- 239000004365 Protease Substances 0.000 title description 3
- 108090000526 Papain Proteins 0.000 title description 2
- 229940055729 papain Drugs 0.000 title description 2
- 235000019834 papain Nutrition 0.000 title description 2
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 28
- 229920000126 latex Polymers 0.000 claims abstract description 23
- 239000004816 latex Substances 0.000 claims abstract description 23
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 18
- 238000002360 preparation method Methods 0.000 claims abstract description 11
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 6
- 238000000746 purification Methods 0.000 claims abstract description 4
- 238000006386 neutralization reaction Methods 0.000 claims abstract description 3
- 235000006264 Asimina triloba Nutrition 0.000 claims description 25
- 239000012528 membrane Substances 0.000 claims description 14
- 238000001556 precipitation Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 10
- 239000001913 cellulose Substances 0.000 claims description 9
- 229920002678 cellulose Polymers 0.000 claims description 9
- 238000000502 dialysis Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 239000008367 deionised water Substances 0.000 claims description 7
- 229910021641 deionized water Inorganic materials 0.000 claims description 7
- 229910001385 heavy metal Inorganic materials 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 5
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 5
- 238000010612 desalination reaction Methods 0.000 claims description 5
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 238000000859 sublimation Methods 0.000 claims description 4
- 230000008022 sublimation Effects 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- 238000002061 vacuum sublimation Methods 0.000 claims description 3
- 239000011261 inert gas Substances 0.000 claims description 2
- 244000189799 Asimina triloba Species 0.000 claims 6
- 238000011109 contamination Methods 0.000 claims 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims 1
- 239000000920 calcium hydroxide Substances 0.000 claims 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims 1
- 239000012535 impurity Substances 0.000 abstract description 8
- 230000008569 process Effects 0.000 abstract description 5
- 238000003916 acid precipitation Methods 0.000 abstract description 4
- 239000003513 alkali Substances 0.000 abstract description 4
- 241000219173 Carica Species 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 238000010828 elution Methods 0.000 abstract description 2
- 238000004108 freeze drying Methods 0.000 abstract 1
- 240000006432 Carica papaya Species 0.000 description 19
- 239000000243 solution Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 12
- 239000000427 antigen Substances 0.000 description 9
- 102000036639 antigens Human genes 0.000 description 9
- 108091007433 antigens Proteins 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 238000005189 flocculation Methods 0.000 description 5
- 230000016615 flocculation Effects 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000004520 agglutination Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000701 coagulant Substances 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 210000003617 erythrocyte membrane Anatomy 0.000 description 2
- 208000001031 fetal erythroblastosis Diseases 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 239000007974 sodium acetate buffer Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241000040710 Chela Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000003771 laboratory diagnosis Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229920006173 natural rubber latex Polymers 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000005554 pickling Methods 0.000 description 1
- 108010024951 plastein Proteins 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229910021654 trace metal Inorganic materials 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002912 waste gas Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
Abstract
The present invention relates to a method for making blood group and cross matching diagnostic reagent by using latex of subtropical papaya. Its technological process includes the steps of acid precipitation, alkali neutralization, chromatography and purification, elution, ultrafiltration and freeze-drying. The blood preparation made up by using said invented method is low in cost, small in impurity, high in yield and high in enzymic specific activity.
Description
The present invention relates to a kind of diagnostic reagent that is used for blood group and cross matching, be used for the external immunological experiments of blood group system such as Rh, Kidd, particularly prepare the method for blood group and cross matching diagnostic reagent with the natural rubber latex of subtropical crop pawpaw.
Papoid begins experimental technique as a kind of blood group immunological response from nineteen forty-seven, its significant feature mechanism is that papoid is that a kind of natural plant contains sulfydryl (SH) endopeptidase, this enzyme have proteolytic enzyme and lipase activity, specificity is more widely arranged, animal and plant albumen, polypeptide, ester, acid amides etc. there is stronger hydrolysis ability, and possess the function that can repeat protolysate again plastein especially, for other enzymes can not be compared.Use the hydrolytic action of papoid erythrocyte membrane protein antigen is carried out restricted modification, blood group antigen such as Rh, Kidd are fully exposed, thereby realization antigen---antibody mediated immunity reaction, can be used for the blood donor, the phenotype diagnosis of Rh (D) the type blood group antigen of aspects such as blood recipient, pregnant person, hemolytic disease of newborn, the classification diagnosis of antibody.
ICSH (ICSH), International Society for the Study of Behavioural Development (ISBT), FDA (FDA) united in 1994 convened international 22 tame laboratories once to papoid the reaction on blood immunology work on a large scale, authenticated papoid to Rh (D) blood group system immuno agglutination reaction by summary, in best enzyme activity scope, under the condition of optimum manipulation method, it is sensitive laboratory diagnosis method, its result of experiment is better than the low ionic strength method, consistent side by side with antihuman globulin method diagnostic result, and expense is lower than above-mentioned two methods, and is easy to operate.The units concerned of international organization have unified the standardized content of papoid as blood grouping reagent for this reason, think to be necessary to produce the papoid preparation that a kind of special blood supply liquid immunological experiment uses, to guarantee the verity of experimental result.
At present external basic medical research developed country, amynologic diagnostic method to the Rh blood group system, make laws by medical administrative department, become the routine inspection project of medical institutions, Blood Center, China's " China's blood transfusion regulations for technical operation "-97 editions, " national Clinical Laboratory working specification "-97 editions is with the prefered method of plank protease method as Rh blood group system immunology detection.Also adopting enzyme process to carry out the blood group immunological experiment as front three hospital Blood Transfusion Department, blood bank checks and accepts one of content in the standard for acceptance of front three hospital in the Ministry of Health.
General crowd's blood group is under the main typing of blood situation with ABO, most of people's whiles are also being deposited Rh blood group antigen or Rh blood group antibody, investigation in China before according to 1985, Rh antigen positive person accounts for 99.6% among the crowd of Han nationality, the Rh of ethnic minority antigen positive person accounts for 95%, the frequency that detects of the crowd of Han nationality imperfection antibody is 0.3-2.0%, and the frequency that detects of ethnic minority's imperfection antibody is significantly higher than Han nationality.Because the recall rate of medical treatment, marriage, fertility, the recent crowd's imperfection of movement of population antibody will have rising greatly.And medically conventional blood group experiment or cross matching experiment, can only diagnose the blood epidemic disease immunology agglutination reaction that is caused by thoroughness antibody, distinguishing abo blood group and intermiscibility thereof, can obtain diagnostic result and can only under 37 ℃ of conditions, experimentize by reagent such as papoids for the Rh blood group immuno agglutination reaction that is caused by imperfection antibody.
Because Rh blood group system and ABO blood group system have status of equal importance on clinical medicine, lifelong disabled because of the immune response of Rh blood group system can cause blood recipient's death, the generation of malpractices such as stillborn foetus, hemolytic disease of newborn.This shows, use this nontoxic pure natural reagent of papoid, safe and reliable, experiment accurately, and is significant.
Papaya (cayica papava) is a kind of torrid zone, subtropical plant, it is to physical environment, weather, soil has certain requirement, the whole world mainly contains South East Asia, the plantation of small parts such as South America area, China also has only Guangdong and Guangxi Provinces, Hainan, Yunnan, Fujian, Guizhou, several provinces and regions such as Taiwan can be planted, but it is edible as fruit or vegetables that pawpaw plantation always mainly is a picking fruit, the latex that also begins in recent years to utilize pawpaw fruit or cane to gather is made Chemicals and biological products, main effective constituent papoid (papaia) in the pawpaw latex, Disken (chymapapain), pawpaw peptase (papaya pept-dasa) etc., hydrolysis ability is in various degree all arranged, but from pawpaw latex, extract blood group diagnosis papoid also in the exploratory stage, purify with special reagent after the external general employing pickling, separating impurity, but special reagent still maintaining secrecy, and domestic also have some units to produce as a trial, but its cost of manufacture height, the purification difficulty is big, cost an arm and a leg, purposes is also failed more developing, so the papoid biochemical products still have many domestic blanks that are.
It is simple to the purpose of this invention is to provide a kind of leaching process, the yield height, and foreign matter content is few, and cost is low, can be used for the high purity of Rh blood group system diagnosis, the extracting method of the papoid of height ratio vigor.
The raw material sources that are used to extract papoid are in following several respects, 1. the fresh latex of gathering and obtaining from bright pawpaw or cane.2. the air-dry thing of pawpaw latex or dry thing.3. through the pawpaw latex product of other preliminary Physical Processing.
The present invention is used for the papoid of Blood Preparations owing to being used as pharmaceutical reagent, and the essential strictness of preparation process is controlled, and also should avoid other chemical substances to mix in the impurity while of removing inside and pollute and destroy its character, below the processing step of summary production:
One, Acid precipitation impurity elimination:
Because the natural latex of gathering back of pawpaw contains more impurity, and some unwanted chemical ingredientss are arranged and deposit, need be with these Impurity removals before refining, the method for removing is that the latex that receipts are adopted is back diluted with 1: 3 with deionized water, by filtering or centrifugal removal leaf and silt.Add thin liquids such as mineral acid example hydrochloric acid, sulfuric acid, phosphoric acid then, PH is transferred to 1-3, place, impurity in the latex is precipitated out under acidic conditions, in the Acid precipitation process, should under 4 ℃ of temperature, carries out during work, the limit adds sour limit and stirs evenly, acid is dispersed evenly in the latex, in order to avoid cause damage because of temperature variation influences enzyme activity too greatly, throw out is by filtering or centrifugal removing.
Two, alkali neutralization:
Through the filtrate of Acid precipitation, because solution is acid, neutralize, neutralizing agent uses mineral alkali, especially at NaOH, KOH, Ca (OH)
2In choose, with solution PH to neutral, about PH7, through semi-permeable membranes dialysis desalination.
Three, remove heavy metal:
The pawpaw latex of handling through acid ﹠ alkali liquid, also may exist the heavy metal element of trace, in order to obtain highly purified product, above-mentioned solution reductive agent be can be added such as dithiothreitol (DTT) activates, and sequestrant such as EDFA, consumption 1-2/ ‰ added, heavy metals such as copper in the solution, copper, iron, cadmium are removed, separate by dialysis, but that most of pawpaw planting site contains heavy metal element is atomic, visual generally speaking raw material is surveyed the inspection situation and this step that decides what to use.
Four, chromatography and purifying:
For the purity that improves papoid and the performance of reagent, need it is carried out chromatography and purifying, chromatography is to adopt the interpolation neutral salt to carry out, the above-mentioned pawpaw latex by volume that obtains is calculated, add the ammonium sulfate powder, make concentration reach 40-50%, placed 0.5-1 hour, allow the papoid crystalline deposit, centrifugal or press filtration separates.
Throw out is dissolved with small amount of deionized water, put PH5.0 in 0.01M acetic acid-sodium-acetate buffer into, put into the CMC-cellulose ion post of crossing through the equal abundant balance of damping fluid, enzyme solution approximates the ion column triplication, carry out ionic adsorption, allow positively charged papoid gene be combined on the CMC-cellulose carrier, thereby obtain further chromatography purification.
Five, wash-out:
Elution process is by elutriant papoid to be cemented out from the desorb selectively of above-mentioned CMC-cellulose carrier, to obtain the best effective ingredient of target product, the eluent that the present invention uses always is 0.01M acetic acid, sodium-acetate buffer PH5.0 wash-out, hac buffer is added ion column with certain flow rate, collect protein peak, till the effluent liquid protein ingredient is minimum.
Six, ultra-filtration and separation concentrates:
The papoid that from elutriant, reclaims, can use ultrafiltration membrane treatment, molecular sieving technology by ultra-filtration membrane, particulate and moisture content in bacterium in the papoid behind the purifying, virus, the latex solid are removed, ultra-filtration process can also make the papoid behind the purifying be concentrated, shorten time of drying significantly, reduces manufacturing cost and improve the quality of products.The present invention adopts the hollow fiber ultrafiltration membrane of molecular weight cut-off 10000 units, rejection can reach 93%, this ultra-filtration membrane mild condition, no phase change, be difficult for causing material damage, the macromolecular substance of papoid is retained down, and water and small molecular weight impurity can see through filter membrane, thereby reach the purpose that concentrates with purifying.
In ultra-filtration process, can adopt flocculation technique and ultra-filtration technique to combine, extract yield is improved and the shortening time.Flocculence be with the papoid liquid behind a certain amount of wash-out under constantly stirring, slowly add a certain amount of polysaccharide flocculant, after adding inorganic coagulant aids adjusting PH more successively, staticly settle after stirring, centrifuging is measured the transparence and the enzyme of supernatant liquor and is lived, and described polyose flocculation agent is avirulent fc-1, addition 0.2g/L, PH5.0-5.5, inorganic flocculation coagulant aids are fc-2 dosage 0.2g/LPH5.0-5.5.Ultrafiltration and concentration is that hollow fiber ultrafiltration membrane is cleaned with deionized water, and the above-mentioned clear liquid control certain pressure that will cross through flocculation treatment and flow cycling stream are crossed the ultrafiltration post and got final product up to the moisture content amount is minimum then.
Seven, lyophilize:
With the above-mentioned ultrafiltration and concentration liquid weighing bottling that makes, putting in the loft drier of freeze drier-20～-35 ℃ then into carries out quick-frozen and freezes, extract dry moisture content situation at vacuum pump then and under-20～-35 ℃, carry out sublimation drying, in bottle, add inert gas or nitrogen behind the dried powdered and preserve sealing, in order to avoid enzyme deactivation, then in preserving below 4 ℃.
The product of papoid is differentiated available ultraviolet method discriminating, and by relevant home or overseas standard test, the present invention adopts the Sodium phosphate dibasic method to do qualitative analysis, and water casein method and spectrophotometry are done quantitative analysis.Ratio vigor 〉=750 units/the mg of papoid.
The present invention compared with the prior art, its outstanding substantive distinguishing features and obvious improvement is:
1. raw material sources are extensive, can extract papain from pawpaw, and ground such as the Guangdong and Guangxi Provinces of China, Yunnan, Fujian all can be cultivated, and the conditional request of pawpaw cultivation is not high, and the plantation pawpaw not only can be gathered in the crops fruit and also can be gathered in the crops latex and make biotechnological formulation.
2. present Blood Preparations extraction cost height, China is populous, most of dependence on import of past, annual about 400,000,000 person-times of need carry out serological blood group diagnosis and cross matching experiment, the import fee that year has spent approximately reaches 600,000,000 yuan more than, the exploitation of this project will provide product for China, reduce the foreign exchange expenditure.
3. the storage temperature of some blood system needs-20 ℃ at present, and papoid of the present invention is kept at 4 ℃ above freezing and gets final product, and does not need cryogenics and equipment, has reduced storage and running cost.
4. the pure natural reagent that makes with product of the present invention is nontoxic, safe and reliable, meets medical quality requirements fully.
5. papoid of the present invention, owing to can modify the antigen of erythrocyte membrane protein, strengthen blood group system antigen body immune responses such as Rh, Kidd, but also destroy the antigenicity of part blood group antigen, as blood groups such as M, N, Fya, Fyb, so can make blood group and cross matching detection single stage method and two step method diagnose out correct result, papoid can detect red corpuscle Rh (D) blood group system or change anti-E, anti-C, anti-Jk into
a, and can identify the feminine gender and the positive exactly, thus the generation of stopping malpractice.
6. method of the present invention is simple, and the manufacturing price of product is low, the yield height, and production process does not have waste water and gas to pollute.
Below be embodiments of the invention:
Embodiment one:
Get the fresh pawpaw latex of gathering, after pressing 1: 3 dilution proportion coarse filtration of whey slag with deionized water earlier, add hydrochloric acid 30% solution, transferring PH is 2, left standstill 1 hour, the centrifugal precipitation of removing, supernatant liquor adds the NaOH diluent and transfers about PH7, semi-permeable membranes dialysis desalination, get supernatant liquor and add dithiothreitol (DTT) and chela and contain each 1 ‰ consumption of agent EDTA, trace heavy metal is removed in dialysis, removes precipitation, filtrate slowly adds the ammonium sulfate powder, amount to be added reaches at 45% o'clock and leaves standstill, and allows precipitation separate out, and takes out precipitation and adds the triplication of deionized water by last ion column, solution acetate buffer solution (0.01M, PH5.0) the fully balance CMC-cellulose column absorption of crossing is used 0.01M, PH5.0 acetate buffer solution wash-out, collect protein peak, make the outflow aqueous solution contain albumen and stop the most after a little while, behind ultrafiltration and concentration, trace is bottled with elutriant, add freeze drier and carry out freezing vacuum low temperature-30 ℃ sublimation drying, get finished product.
Embodiment two:
Get air-dry pawpaw latex, add earlier 5 times of water dissolution by weight, adding dilute sulphuric acid adjusting PH is 3, left standstill 2 hours, and the centrifugal precipitation of removing, clear liquid adds Ca (OH)
2Solution is transferred about PH7, with semi-permeable membranes dialysis desalination, get supernatant liquor add dithiothreitol (DTT) and sequestrant EDTA each 1.5 ‰, trace-metal salt is removed in dialysis, remove precipitation, filtrate adds ammonium sulfate, make when reaching strength of solution 40% and leave standstill, separate out precipitation, take out the precipitate with deionized water dilution, and to transfer PH with hac buffer be about 5, add polysaccharide flocculant fc-1 precipitation, with the absorption of CMC-cellulose column, the acetic acid of using 0.01MPH5.0 again is towards eluant solution then, collect protein peak, contain to flowing out the aqueous solution that albumen is minimum to be stopped, with elutriant behind the hollow-fibre membrane ultrafiltration and concentration of 1000 units by volume or the weight bottling, get finished product with-25 ℃ vacuum and low temperature sublimation dryings, last in bottle, add nitrogen and preserve, can never degenerate in 3 years at 0-4 ℃ refrigerator.
Embodiment three:
Get the pawpaw fresh latex and add 3 times of dilutions of double distilled water, add 30% phosphoric acid, transferring PH is 1, leaves standstill half an hour, with contaminant filter, solution adds NaoH to be transferred about PH to 7, with semi-permeable membranes dialysis desalination, adds ammonium sulfate to solution then and reaches 50%, place and allowed its precipitation in 1 hour, with the double distilled water dilution, put to the absorption of CMC-cellulose carrier, with the flushing of PH5.0 hac buffer, collect protein peak, make the basic wash-out of papoid, add polysaccharide flocculant flocculation (also can flocculate) again, concentrate with the hollow cellulose membrane ultrafiltration, the back bottling, vacuum-sublimation drying under-35 ℃ of low temperature obtains finished product, transports blood station or hospital to and preserves in 4 ℃ of refrigerators.
Claims (5)
1. method of utilizing pawpaw latex to produce blood group diagnose reagent preparation, it is characterized in that its processing step is: (1), adds mineral acid contamination precipitation is separated towards rare or dissolving pawpaw latex with deionized water; (2) add sodium hydroxide or potassium hydroxide, calcium hydroxide neutralization, and with semi-permeable membranes dialysis desalination; (3) remove trace heavy metal; (4) chromatography and purifying; (5) wash-out of papoid; (6) use the ultra-filtration membrane ultrafiltration; (7) cryogenic vacuum sublimation drying; (8) adding inert gas or nitrogen-sealed preserves.
2. the method for utilizing pawpaw latex to produce blood group diagnose reagent preparation according to claim 1, it is characterized in that adding mineral acid, contamination precipitation to be separated be the PH that adds hydrochloric acid or sulfuric acid regulation solution be 1-3.
3. the method for utilizing pawpaw latex to produce blood group diagnose reagent preparation according to claim 1, it is characterized in that chromatography and purifying are to be added to the solution of removing behind the trace heavy metal with the ammonium sulfate powder to make the papoid crystalline deposit, transfer PH to 5 then, use the CMC-cellulose purification.
4. the method for utilizing pawpaw latex to produce blood group diagnose reagent preparation according to claim 1, the wash-out that it is characterized in that papoid is the papoid that is eluted in the CMC-cellulose purification with the hac buffer of PH5.
5. the method for utilizing pawpaw latex to produce blood group diagnose reagent preparation according to claim 1 is characterized in that the cryogenic vacuum sublimation drying is to carry out sublimation drying in-20～-35 ℃ under vacuum pump draws water part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99108817A CN1093173C (en) | 1999-06-19 | 1999-06-19 | Papain blood group diagnose reagent prepn. method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99108817A CN1093173C (en) | 1999-06-19 | 1999-06-19 | Papain blood group diagnose reagent prepn. method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1242429A true CN1242429A (en) | 2000-01-26 |
| CN1093173C CN1093173C (en) | 2002-10-23 |
Family
ID=5273528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99108817A Expired - Fee Related CN1093173C (en) | 1999-06-19 | 1999-06-19 | Papain blood group diagnose reagent prepn. method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1093173C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102286609A (en) * | 2011-06-22 | 2011-12-21 | 北京工商大学 | Method for detecting heavy metal pollution by using papain |
| CN114181925A (en) * | 2020-09-14 | 2022-03-15 | 武汉禾元生物科技股份有限公司 | Industrial purification and freeze-drying method for recombinant proteinase K |
| US11604026B2 (en) | 2019-03-14 | 2023-03-14 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
| US11634257B2 (en) | 2017-10-09 | 2023-04-25 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1037698C (en) * | 1992-12-24 | 1998-03-11 | 中国科学院昆明植物研究所 | Refined enzyme purification process for papain |
-
1999
- 1999-06-19 CN CN99108817A patent/CN1093173C/en not_active Expired - Fee Related
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102286609A (en) * | 2011-06-22 | 2011-12-21 | 北京工商大学 | Method for detecting heavy metal pollution by using papain |
| CN102286609B (en) * | 2011-06-22 | 2013-01-02 | 北京工商大学 | Method for detecting heavy metal pollution by using papain |
| US11634257B2 (en) | 2017-10-09 | 2023-04-25 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
| US11604026B2 (en) | 2019-03-14 | 2023-03-14 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
| US11609042B2 (en) | 2019-03-14 | 2023-03-21 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
| US11609043B2 (en) | 2019-03-14 | 2023-03-21 | Terumo Bct Biotechnologies, Llc | Lyophilization container fill fixture, system and method of use |
| US11740019B2 (en) | 2019-03-14 | 2023-08-29 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
| US11747082B2 (en) | 2019-03-14 | 2023-09-05 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
| US11815311B2 (en) | 2019-03-14 | 2023-11-14 | Terumo Bct Biotechnologies, Llc | Lyophilization container fill fixture, system and method of use |
| US11994343B2 (en) | 2019-03-14 | 2024-05-28 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
| CN114181925A (en) * | 2020-09-14 | 2022-03-15 | 武汉禾元生物科技股份有限公司 | Industrial purification and freeze-drying method for recombinant proteinase K |
| CN114181925B (en) * | 2020-09-14 | 2025-01-17 | 武汉禾元生物科技股份有限公司 | Industrial purification and freeze-drying method for recombinant proteinase K |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1093173C (en) | 2002-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104530207B (en) | A kind of method that soybean agglutinin is isolated and purified from soy-bean whey | |
| WO2022067774A1 (en) | Preparation method and application of sea cucumber polysaccharide | |
| CN102621329A (en) | Bird's-nest enzyme linked immunosorbent assay kit | |
| CN102351917A (en) | Method for extracting raffinose from cotton seed meal | |
| CN104387443A (en) | Method for efficiently recycling protein and free amino acid from potato starch processing wastewater | |
| CN101907627A (en) | Clenbuterol hydrochloride magnetic particle separation enzyme-linked immunosorbent assay method | |
| CN102676484B (en) | Process for preparing high-purity bovine trypsin | |
| CN105624251A (en) | Peony seed blood sugar decreasing peptide and purification method and application thereof | |
| CN101816789B (en) | Lyophilized viper antivenin and preparation method thereof | |
| CN102617746A (en) | Method for preparing multiple oligosaccharides by separating and purifying Chinese dates | |
| CN1093173C (en) | Papain blood group diagnose reagent prepn. method | |
| Mueller et al. | The chemical nature of residue antigen prepared from yeast | |
| CN104292316A (en) | Efficient separation and purification method of Gracilaria verrucosa reagent grade R-phycoerythrin | |
| CN112707852B (en) | Combined preparation method of garlic extract | |
| CN102174095B (en) | Malania oleifera lectin and method for preparing same | |
| CN109354601A (en) | A kind of extraction method of selenoprotein in pear fruit | |
| CN107177459A (en) | A kind of earthworm polypeptide wine and preparation method thereof | |
| Seibert et al. | The Chemical Composition of the Active Principle of Tuberculin: XIV. Analysis of the Colloidal Components of Tuberculin with Special Reference to the Relation of Protein and Carbohydrate | |
| CN102199191B (en) | Sealing system composed of small anaerobic operation bags and chromatography column in series | |
| CN102925416A (en) | Method for extracting superoxide dismutase from blood of mammal | |
| CN114605515A (en) | Separation and purification process of high-activity phytohemagglutinin | |
| CN110483653B (en) | A kind of preparation method, product and application of lentinan component with immune activity | |
| CN1087947A (en) | Produce the method for superoxide-dismutase from corn kernel | |
| SU1131507A1 (en) | Method of obtaining insulin | |
| CN112063606A (en) | Method for rapidly extracting shellfish digestive endogenous enzyme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |